Cite
Evolution of HCV treatments with direct acting antivirals between 2014 and 2017 in 8637 HCV patients in a real world setting: A report from the Lombardia Network and Navigator Study Group.
MLA
Degasperi, E., et al. “Evolution of HCV Treatments with Direct Acting Antivirals between 2014 and 2017 in 8637 HCV Patients in a Real World Setting: A Report from the Lombardia Network and Navigator Study Group.” Digestive & Liver Disease, vol. 50, Feb. 2018, p. 52. EBSCOhost, https://doi.org/10.1016/j.dld.2018.01.058.
APA
Degasperi, E., Pasulo, L., Aghemo, A., Puoti, M., Zaltron, S., Maggiolo, F., Rizzardini, G., Fargion, S., Sacchi, P., Gulminetti, R., Zuin, M., Quirino, T., Rumi, M. G., Pan, A., Grossi, P., Rossini, A., Corbellini, A., Uberti Foppa, C., Colli, A., & Piovesan, S. (2018). Evolution of HCV treatments with direct acting antivirals between 2014 and 2017 in 8637 HCV patients in a real world setting: A report from the Lombardia Network and Navigator Study Group. Digestive & Liver Disease, 50, 52. https://doi.org/10.1016/j.dld.2018.01.058
Chicago
Degasperi, E., L. Pasulo, A. Aghemo, M. Puoti, S. Zaltron, F. Maggiolo, G. Rizzardini, et al. 2018. “Evolution of HCV Treatments with Direct Acting Antivirals between 2014 and 2017 in 8637 HCV Patients in a Real World Setting: A Report from the Lombardia Network and Navigator Study Group.” Digestive & Liver Disease 50 (February): 52. doi:10.1016/j.dld.2018.01.058.